Skip to content
Tenfell
Awarded contract
Published 08 Mar 2022

National Procurement for HIV and Preventative Treatments

NHSE&I

Key facts

Awarded
01 Feb 2022
Contract starts
01 Feb 2022
Contract ends
31 Jul 2023
Procedure
Open procedure (above threshold)
Buyer type
Other public body

Awarded to 15 suppliers

SupplierValue
Dr Reddy's Laboratories (UK) Ltd—
Janssen-Cilag Ltd—
Teva UK Ltd—
Abbvie Ltd—
Gilead Sciences Limited—
Merck Sharpe & Dohme (UK) Limited—
Mylan—
Zentiva Pharma UK Ltd—
Amarox Limited—
Tillomed Laboratories ltd—
ViiV Healthcare UK Ltd—
Glenmark Pharmaceuticals Europe Ltd—
Lupin Healthcare UK Ltd—
Mawdsley Brooks & Co Ltd—
Macleods Pharma UK Limited—

Description

Lot 1 - supply of licensed antiretroviral therapy (ART) for the treatment of HIV (Adults and Children) and licensed pre-exposure prophylaxis (PrEP) packs for the prevention of HIV. Lot 2 - a service to supply over labelled post-exposure prophylaxis (PEP) packs for the prevention of HIV.

Categories (CPV)

Similar open tenders

About NHSE&I

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.